Skip to main content

Secarna Pharmaceuticals: Data published in Molecular Diagnostics & Therapy demonstrate how Secarna’s powerful bioinformatics generate improved LNA-modified antisense oligonucleotide therapies

Written by Petra Hegmann on . Posted in Client News.